Research Focus

Former Employee. SKI Medicine; Vacation Relief

Recent additions – View all

1. BIBF1120, an investigational triple angiokinase inhibitor, in combination with inhibitors of mTOR signaling shows potent antitumor activity in preclinical models of sarcoma

   Meeting Abstract

   Patwardhan, P. P.; Musi, E.; Ivy, K. S.; Giovino, N.; Schwartz, G. K.
   Cancer Research (2014)

   Fulltext@MSK | Save